Treatment and Survival of Patients With High-Risk HR+/HER2− Breast Cancer in the Netherlands
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study
ESMO Open 2024 Apr 26;9(5)103008, SWM Lammers, M Meegdes, IJH Vriens, AC Voogd, L de Munck, TJA van Nijnatten, KBMI Keymeulen, VCG Tjan-Heijnen, SME GeurtsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.